Login Register Cart 0
Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Procalcitonin Biomarker for Sepsis in Postoperative Pediatric Trauma Patients: Three Years of Experience from a Tertiary University Hospital

Author(s): Waleed H. Albuali*

Volume 19, Issue 3, 2023

Published on: 07 October, 2022

Page: [296 - 303] Pages: 8

DOI: 10.2174/1573396318666220912093557

Price: $65

Abstract

Background: The biomarker procalcitonin (PCT) is good in detecting sepsis in postoperative pediatric trauma patients, especially those with a high suspicion of sepsis, and formulating a quick treatment. Its use is still limited to pediatric surgical patients, particularly those in intensive care units (ICUs), who are more susceptible to sepsis. The purpose of this study was to see if procalcitonin could be used as a reliable and quick biomarker for sepsis in postoperative pediatric trauma patients and were brought to the PICU.

Methods: This retrospective longitudinal study was conducted from January 2017 to December 2019. Postoperative pediatric trauma patients aged > 2 weeks old who were hospitalized at the PICU of King Fahd Hospital of the University due to serious trauma or post-acute surgical events were included. Within 24 hours of admission, PCT levels were measured, and again 48-72 hours later.

Results: In our study, 31% of severely ill children developed post-surgical sepsis. When compared to the PRISM III score and 24-hour PCT level, PCT levels at 48-72 hours exhibited the largest area under the curve (AUC). With a sensitivity of 71% and a specificity of 65%, the predictive AUC value was estimated to be 0.71. The AUC of PCT levels at 48-72 hours was 0.72 (95% confidence interval (CI): 0.65-0.79; p < 0.001), indicating high predictive validity using a cutoff point > 0.10, with sensitivity, specificity, and positive and negative predictive values of 68.4%, 63.6%, 45.8%, and 81.8%, respectively.

Conclusion: PCT is a sensitive biomarker for detecting sepsis in postoperative pediatric trauma patients, especially those with a high pre-test suspicion for sepsis. In addition, PCT can be used alone or in combination with other clinical findings to help formulate a rapid primary diagnosis of sepsis in this subset of patients.

Keywords: Biomarker, Pediatric Intensive Care Unit, Procalcitonin, Sepsis, Trauma, Ventilation.

« Previous Next »
Graphical Abstract

[1]
Bayreuther J, Wagener S, Woodford M, et al. Paediatric trauma: Injury pattern and mortality in the UK. Arch Dis Child Educ Pract Ed 2009; 94(2): 37-41.
[http://dx.doi.org/10.1136/adc.2007.132787] [PMID: 19304898]
[2]
Mckechnie PS, Wertin T, Parker P, Eckert M. Pediatric surgery skill sets in role 3: The Afghanistan experience. Mil Med 2014; 179(7): 762-5.
[http://dx.doi.org/10.7205/MILMED-D-13-00513] [PMID: 25003861]
[3]
Weiss SL, Fitzgerald JC, Pappachan J, et al. Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and thera-pies study. Am J Respir Crit Care Med 2015; 191(10): 1147-57.
[http://dx.doi.org/10.1164/rccm.201412-2323OC] [PMID: 25734408]
[4]
Ruth A, McCracken CE, Fortenberry JD, Hall M, Simon HK, Hebbar KB. Pediatric severe sepsis: Current trends and outcomes from the pediatric health information systems database. Pediatr Crit Care Med 2014; 15(9): 828-38.
[http://dx.doi.org/10.1097/PCC.0000000000000254] [PMID: 25226500]
[5]
Kissoon N, Carcillo JA, Espinosa V, et al. Global sepsis initiative vanguard center contributors: World federation of pediatric intensive care and critical care societies: Global sepsis initiative. Pediatr Crit Care Med 2011; 12(5): 494-503.
[http://dx.doi.org/10.1097/PCC.0b013e318207096c] [PMID: 21897156]
[6]
Kessler U, Ebneter M, Zachariou Z, Berger S. Postoperative sepsis in infants below 6 months of age. World J Pediatr 2009; 5(2): 113-7.
[http://dx.doi.org/10.1007/s12519-009-0022-5] [PMID: 19718532]
[7]
Mariza ZO, Gkentzi D, Gogos C, Akinosoglou K. Biomarkers in pediatric sepsis: A review of recent literature. Biomarkers Med 2020; 14(10): 895-917.
[http://dx.doi.org/10.2217/bmm-2020-0016]
[8]
Lanziotti VS, Póvoa P, Soares M, Silva JRL, Barbosa AP, Salluh JIF. Use of biomarkers in pediatric sepsis: Literature review. Rev Bras Ter Intensiva 2016; 28(4): 472-82.
[http://dx.doi.org/10.5935/0103-507X.20160080] [PMID: 28099644]
[9]
Meynaar IA, Droog W, Batstra M, Vreede R, Herbrink P. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and sirs than CRP, IL-6, or LBP. Crit Care Res Pract 2011; 2011, 594645.
[http://dx.doi.org/10.1155/2011/594645] [PMID: 21687569]
[10]
Castelli G, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory re-sponse syndrome, sepsis and organ dysfunction. Crit Care 2004; 8(4): R234-42.
[http://dx.doi.org/10.1186/cc2877] [PMID: 15312223]
[11]
Bobillo PS, Rodríguez FJ, Jordan GI. Is procalcitonin useful in pediatric critical care patients? Biomark Insights 2018; 13: 1-10.
[http://dx.doi.org/10.1177/1177271918792244] [PMID: 30093797]
[12]
Lautz AJ, Dziorny AC, Denson AR, et al. Value of procalcitonin measurement for early evidence of severe bacterial infections in the pedi-atric intensive care unit. J Pediatr 2016; 179: 74-81.e2.
[http://dx.doi.org/10.1016/j.jpeds.2016.07.045] [PMID: 27587074]
[13]
Iankova I, Thompson LP, Kirson NY, et al. Efficacy and safety of procalcitonin guidance in patients with suspected or confirmed sepsis: A systematic review and meta-analysis. Crit Care Med 2018; 46(5): 691-8.
[http://dx.doi.org/10.1097/CCM.0000000000002928] [PMID: 29271844]
[14]
Saleh MAA, Van De Garde EMW, Van Hasselt JGC. Host-response biomarkers for the diagnosis of bacterial respiratory tract infections. Clin Chem Lab Med 2019; 57(4): 442-51.
[http://dx.doi.org/10.1515/cclm-2018-0682] [PMID: 30183665]
[15]
Evans T. Diagnosis and management of sepsis. Clin Med 2018; 18(2): 146-9.
[http://dx.doi.org/10.7861/clinmedicine.18-2-146] [PMID: 29626019]
[16]
Pontrelli G, De Crescenzo F, Buzzetti R, et al. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: A meta-analysis. BMC Infect Dis 2017; 17(1): 302.
[http://dx.doi.org/10.1186/s12879-017-2396-7] [PMID: 28438138]
[17]
Zimmerman JJ, Sullivan E, Yager TD, et al. Diagnostic accuracy of a host gene expression signature that discriminates clinical severe sep-sis syndrome and infection-negative systemic inflammation among critically ill children. Crit Care Med 2017; 45(4): e418-25.
[http://dx.doi.org/10.1097/CCM.0000000000002100] [PMID: 27655322]
[18]
McCoy A, Das R. Reducing patient mortality, length of stay and readmissions through machine learning-based sepsis prediction in the emergency department, intensive care unit and hospital floor units. BMJ Open Qual 2017; 6(2), e000158.
[http://dx.doi.org/10.1136/bmjoq-2017-000158]
[19]
Albuali WH, Algamdi AA, Hasan EA, et al. Use of a mortality prediction model in children on mechanical ventilation: A 5-year experience in a tertiary university hospital. J Multidiscip Healthc 2020; 13: 1507-16.
[http://dx.doi.org/10.2147/JMDH.S282108] [PMID: 33204099]
[20]
Baker SP, O’Neill B, Haddon W, Long WB. The injury severity score: A method for describing patients with multiple injuries and evaluat-ing emergency care. J Trauma 1974; 14(3): 187-96.
[PMID: 4814394]
[21]
Spoto S, Valeriani E, Caputo D, et al. The role of procalcitonin in the diagnosis of bacterial infection after major abdominal surgery. Medicine 2018; 97(3), e9496.
[http://dx.doi.org/10.1097/MD.0000000000009496] [PMID: 29504973]
[22]
Rey C, Los AM, Concha A, et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med 2007; 33(3): 477-84.
[http://dx.doi.org/10.1007/s00134-006-0509-7] [PMID: 17260130]
[23]
Sinha M, Desai S, Mantri S, Kulkarni A. Procalcitonin as an adjunctive biomarker in sepsis. Indian J Anaesth 2011; 55(3): 266-70.
[http://dx.doi.org/10.4103/0019-5049.82676] [PMID: 21808399]
[24]
Anand D, Das S, Bhargava S, et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: A prospective, observational, cohort study. J Crit Care 2015; 30(1): 218.e7-218.e12.
[http://dx.doi.org/10.1016/j.jcrc.2014.08.017] [PMID: 25263339]
[25]
Sakran JV, Michetti CP, Sheridan MJ, et al. The utility of procalcitonin in critically ill trauma patients. Trauma Acute Care Surg 2012; 73(2): 413-8.
[26]
Vijayan AL. Vanimaya, Ravindran S, et al. Procalcitonin: A promising diagnostic marker for sepsis and antibiotic therapy. J Intensive care 2017; 51.
[http://dx.doi.org/10.1186/s40560-017-0246-8]
[27]
Hamade B, Huang DT. Procalcitonin: Where are we now? Crit Care Clin 2020; 36(1): 23-40.
[http://dx.doi.org/10.1016/j.ccc.2019.08.003]
[28]
Parli SE, Trivedi G, Woodworth A, Chang PK. Procalcitonin: Usefulness in acute care surgery and trauma. Surg Infect 2018; 19(2): 131-6.
[http://dx.doi.org/10.1089/sur.2017.307] [PMID: 29356604]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy